Lets break this down for anyone who's new to the story or hasn't done any research.
1. Zantrene has pre clinical and clinical data spanning 15 years (approved for use in France in the 90's)over 2,000 patients dosed. If you started from scratch today, that data would be worth close to $700 million dollars plus 10 - 15 years of research. That's the most difficult part of drug discovery DONE.
2. In 2019/2020, 10 patients with AML were treated in Israel, these people were very sick, already had 3 lines of treatment and were basically dead people walking. A response in 1 person would have been good, there were 4 patients who got responses, including 1 who had a rare indication of extramedullary. This alone is quite incredible. The drug works and is safe in humans.
3. City of Hope searched 230,000 drug compounds for a link to FTO, (this is believed to be a key driver in cell life and malfunction) they found only one that could be used effectively, CS1 (Zantrene)
4. Clinical mouse models show that Zantrene has cardioprotective and anti cancer properties.
5. I could go on & on & on & on about the drug, research etc, the reality is, Zantrene could be one of the greatest cancer drugs ever discovered, owned by a small Aussie biotech who have just started their 'get on the radar' strategy. It may not sell for hundreds of dollars, but it might. Get a seat at the table, hold on tight and be patient. Why not Zantrene? Why not Aussie investors? There's a lot to like about what's happening.
Do your own research, read, watch, listen and try to get an understanding about what's going on and playing out in front of us, its an unbelievable story.
PS - Between Daniel Tillet and few posters on HC, there's more than 50% of SOI represented, a cheap buyout will more than likely be blocked.
- Forums
- General
- General Comments / Chat
Lets break this down for anyone who's new to the story or hasn't...
- There are more pages in this discussion • 3,696 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.57 |
Change
-0.040(2.49%) |
Mkt cap ! $268.0M |
Open | High | Low | Value | Volume |
$1.59 | $1.62 | $1.56 | $94.40K | 59.44K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 108 | $1.57 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.58 | 294 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 108 | 1.565 |
1 | 5958 | 1.560 |
1 | 1034 | 1.555 |
2 | 7451 | 1.550 |
1 | 653 | 1.530 |
Price($) | Vol. | No. |
---|---|---|
1.575 | 500 | 1 |
1.580 | 294 | 1 |
1.585 | 700 | 1 |
1.595 | 1100 | 1 |
1.600 | 408 | 1 |
Last trade - 15.16pm 05/06/2024 (20 minute delay) ? |
|
|||||
Last
$1.58 |
  |
Change
-0.040 ( 1.25 %) |
|||
Open | High | Low | Volume | ||
$1.58 | $1.62 | $1.56 | 6221 | ||
Last updated 15.45pm 05/06/2024 ? |
Featured News
RAC (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
Previous Video
Next Video
SPONSORED BY The Market Online